The founding institutions of TMC3 have announced a new project team for their planned 37-acre translational research campus in Houston. In April of 2019, Texas Medical Center, Baylor College of Medicine, Texas A&M University Health Science Center, the University of Texas Health Science Center at Houston, and the University of Texas MD Anderson Cancer Center officially awarded the project's design and construction to Elkus Manfredi Architects, Vaughn Construction, and Transwestern Development Company. The master plan will undergo critical updates in design, form, and function to create a biomedical nexus that will combine collaborative research facilities with retail, residential, and lifestyle amenities. The live/work/play district will feature public green spaces in a landscape arranged in the shape of a DNA helix.
Baylor College of Medicine will expand its research and education facilities within the TMC3 campus. Additionally, Baylor St. Luke’s Medical Center will increase its footprint on the McNair Campus with a second hospital tower on TMC3’s eastern edge. Texas A&M Health Science Center's research building will be located on the north end between the TMC3 Hotel and Conference Center and Baylor College of Medicine’s research building. MD Anderson and UTHealth will each develop new research facilities on the south end of the campus, and both will connect to the expanded University of Texas Research Park. The area’s central communal building will take the form of a bustling nerve center called TMC3 Collaborative. The ground floor will comprise an open atrium with a variety of dining venues, with the upper floors housing shared institutional research facilities and space for industry partners. The north end of the reconfigured district will house the Texas Medical Center Hotel and Conference Center, along with a residential tower on the helix promenade. The campus is slated for completion in 2022.